ClinicalTrials.gg
Not yet recruitingNCT07475091Updated Nov 2, 2026

Standardizing Swallow Pressure Measurements

An interventional study of Laborie LMT Pharyngeal System (3.7 mm catheter) and Medtronic ManoScan ESO HRM System (4.2 mm catheter) in Dysphagia, sponsored by University of Wisconsin, Madison. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Diagnostic

Updated Nov 2, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 12 studies in Deglutition Disorders by University of Wisconsin, Madison — 1 open to participants now, 1 under way, none of them phase 3. Deglutition Disorders · University of Wisconsin, Madison.

Started
2026
the only one that year
No phase
5 of 12
1 open now
Registered
12th of 12
by date

Among the 12 studies in Deglutition Disorders by University of Wisconsin, Madison, this one is the only one that started in 2026, is one of 5 with no phase, and was the 12th registered.

Deglutition Disorders

873 studies on the registry are indexed under Deglutition Disorders; 236 are open to participants now.

Browse Deglutition Disorders studies →

Open to participants now

1 of the 12 studies in Deglutition Disorders by University of Wisconsin, Madison is open now, in 1 country.

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 138 Deglutition Disorders studies recruiting now, 75 (54%) set no upper age limit and 27 (20%) stop at 75 or younger; 16 take children under 18; 20 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Deglutition Disorders by University of Wisconsin, Madison, or all of them as a file.
02

Study summary

This study aims to directly compare and contrast swallowing pressure and impedance measurements obtained from two high-resolution manometry (HRM) systems: the Laborie LMT Pharyngeal System and the Medtronic ManoScan ESO HRM System in healthy adult volunteers. The primary objective is to determine how differences in catheter diameter, sensor configuration, and acquisition platforms influence measurement outcomes. Twenty-five healthy adults will participate in a single, approximately 2-hour visit; the study will be open for one year for data collection and two years for data analysis.

Read the detailed description

The primary objective is to obtain, compare, and contrast directly the measured swallow between the Laborie Pharyngeal HRM impedance system with the 3.7 mm catheter and the Medtronic HRM impedance system with the 4.2 mm catheter in the same setting with normal healthy volunteers.

03

Conditions studied

  • Dysphagia

Keywords

  • pharyngeal pressure events
  • swallowing
  • measurement
  • diagnosis
04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • without known swallowing disorders

Exclusion criteria

Exclusion Criteria:

  • Known swallowing disorder
  • Allergy to topical anesthetic
  • Allergy to food relevant to study participation (e.g. lactose intolerance)
  • Inability to follow direction or remain calm during the experiment.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Laborie then Medtronic

    This study will include a data collection session that involves swallowing tasks during HRM.

    Device: Laborie LMT Pharyngeal System (3.7 mm catheter) · Device: Medtronic ManoScan ESO HRM System (4.2 mm catheter)

  • Experimental
    Medtronic then Laborie

    This study will include a data collection session that involves swallowing tasks during HRM.

    Device: Laborie LMT Pharyngeal System (3.7 mm catheter) · Device: Medtronic ManoScan ESO HRM System (4.2 mm catheter)

Interventions

  • DeviceLaborie LMT Pharyngeal System (3.7 mm catheter)

    The Solar GI HRM system is intended to record, store, view, and analyze pressure, impedance, EMG, swallow and respiration, and various auxiliary input device data online anywhere in the gastrointestinal tract (pharynx; esophagus; stomach; duodenum; sphincter of Oddi; small bowel; colon and anorectal area, including rectum and pelvic floor) to assist in the diagnosis and evaluation of gastrointestinal and swallowing disorders. Used with 3.7 mm catheter.

    Also known as: Laborie HRM impedance system, Laborie Solar™ GI HRM Solid-State, Trolley System (G3-9), Laborie Solid State HRIM Catheter (K83659-E-1820-D)

  • DeviceMedtronic ManoScan ESO HRM System (4.2 mm catheter)

    The ManoScan™ ESO high resolution manometry system enables full evaluation of the motor functions of the esophagus. The system provides useful information to support diagnosis of conditions like dysphagia, achalasia, and hiatal hernia. A 36-channel circumferential solid-state catheter with 4.2 mm diameter, 1.0 cm spacing between adjacent sensors.

    Also known as: Medtronic HRM impedance system, Medtronic ManoScan™ ESO high resolution manometry system, Medtronic ManoScan360 HRM catheter

06

What researchers measure

Primary outcomes

  1. Base of tongue pressure

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  2. Hypopharyngeal peak pressure

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  3. Pharyngeal Contractile Integral (PhCI)

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  4. Pressure rise time

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  5. Contractile front velocity

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  6. Upper Esophageal Sphincter (UES) resting pressure

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  7. UES peak contraction pressure

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  8. UES relaxation nadir pressure

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  9. UES relaxation duration

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  10. Nadir impedance

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  11. Bolus presence time

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  12. Flow interval

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  13. Pressure-flow index component

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  14. Timing relationships (onset-to-peak intervals)

    Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.

    Time frame: data collected during 1 study visit (up to 2 hours)

  15. Construction of Spatial pressure distribution maps

    Multi-level modeling for repeated measures across bolus types, volumes, and repetitions. Sensor-level and region-level analyses (BOT, hypopharynx, UES). Agreement thresholds and bias definitions added to facilitate interpretability and ensure clarity for cross-platform comparison. Map layers will be summarized as a proxy for this measure.

    Time frame: data collected during 1 study visit (up to 2 hours)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Sep 2027, 10 months later.

Of 290 non-industry interventional studies with no phase under Deglutition Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 10 months is below that.

Counting every sponsor, half of 299 studies reached it within 21 months; a quarter within 10 and three quarters within 38.

Start moved twice since we started tracking on Sep 25, 2026: Sep 2026 → Nov 2026, last on Nov 2, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 11, 2026
First posted
Mar 16, 2026
StartEst.
Nov 2026was Sep 2026
Primary completionEst.
Sep 2027
CompletionEst.
Sep 2027
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 2026→Nov 2026
moved 2 times, Sep 29, 2026 – Nov 2, 2026
Show all 2 updates
  1. Nov 2, 2026
    Start date Oct 2026→Nov 2026
    + 1 other change: verification date
  2. Sep 29, 2026
    Start date Sep 2026→Oct 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07475091
Responsible party
Sponsor
First posted
Mar 16, 2026
Start date
Nov 2026 (estimated)
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Nov 2, 2026

Study contacts

Suzan Abdelhalim, MD
Contact
abdelhalim@surgery.wisc.edu
608-265-2470
Timothy McCulloch, MD
principal investigator · University of Wisconsin, Madison

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion